Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
A Study of S-268019 for the Prevention of COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers for Post-COVID Conditions
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)
- Status
- COMPLETED
- Phase
- NA
A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
- Status
- COMPLETED
- Phase
- PHASE1
Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus
- Status
- TERMINATED
- Phase
- N/A
Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Convalescent Plasma Therapy for Hospitalized Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant
- Status
- UNKNOWN
- Phase
- N/A
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients
- Status
- UNKNOWN
- Phase
- NA
EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community
- Status
- COMPLETED
- Phase
- NA
Korea Comirnaty Post-marketing Surveillance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neurological Outcome After SARS-CoV-2 Infection
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
- Status
- COMPLETED
- Phase
- N/A
Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination
- Status
- UNKNOWN
- Phase
- N/A